PLx Pharma Winddown Corp. Net Change in Cash
PLx Pharma Winddown Corp. reported Net Change in Cash of -$43.56 million for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-10.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect · last filed 2022-11-10
- PLx Pharma Winddown Corp. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2022-03-31 was -$16.89M, a 127.26% decline year-over-year.
- PLx Pharma Winddown Corp. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2021-03-31 was $61.98M.
- PLx Pharma Winddown Corp. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2020-03-31 was -$4.71M.
- PLx Pharma Winddown Corp. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2021 was $46.94M, a 455.67% increase from fiscal 2020.
- PLx Pharma Winddown Corp. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2020 was $8.45M.
- PLx Pharma Winddown Corp. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2019 was -$248.96K.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month as first filed | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month as first filed | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month as first filed | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2022-09-30 | -$43.56M 10-Q · filed 2022-11-10 | |||||||
| 2022-06-30 | -$33.66M 10-Q · filed 2022-08-12 | |||||||
| 2022-03-31 | -$16.89M 10-Q · filed 2022-05-13 | |||||||
| 2021-12-31 | $46.94M 10-K · filed 2022-03-11 | |||||||
| 2021-09-30 | $60.10M 10-Q · filed 2022-11-10 | $60.11M 10-Q · filed 2021-11-12 | ||||||
| 2021-06-30 | $57.72M 10-Q · filed 2022-08-12 | $57.72M 10-Q · filed 2021-08-06 | ||||||
| 2021-03-31 | $61.98M 10-Q · filed 2022-05-13 | $61.97M 10-Q · filed 2021-05-14 | ||||||
| 2020-12-31 | $8.45M 10-K · filed 2022-03-11 | $8.45M 10-K · filed 2021-03-12 | ||||||
| 2020-09-30 | -$4.91M 10-Q · filed 2021-11-12 | |||||||
| 2020-06-30 | -$744.10K 10-Q · filed 2021-08-06 | |||||||
| 2020-03-31 | -$4.71M 10-Q · filed 2021-05-14 | |||||||
| 2019-12-31 | -$248.96K 10-K · filed 2021-03-12 | |||||||
| 2019-09-30 | $4.26M 10-Q · filed 2020-11-13 | |||||||
| 2019-06-30 | $7.01M 10-Q · filed 2020-08-14 |